Latest Vapotherm Inc. Stories
EXETER, N.H., April 24, 2013 /PRNewswire-USNewswire/ -- On April 12, 2013 Vapotherm closed a $29MM financing round which was led by the 3x5 Special Opportunity Fund L.P. and included new investor Morgenthaler Venture Partners L.P. Existing investors GE Asset Management, Kaiser Permanente, Integral Capital Partners, QuestMark Partners and Cross Creek Capital also participated in the current round. The proceeds from this financing will be used to fund the Company's growth plans. Tony...
STEVENSVILLE, Md., June 26, 2012 /PRNewswire-USNewswire/ -- Vapotherm announced today that its Board of Directors has appointed Joe Army as President and CEO. Most recently, Mr. Army served as CEO of Salient Surgical Technologies of Portsmouth, NH. He also served as the company's CFO from 1999-2006. Salient was acquired by Medtronic in August, 2011. Before Salient, Army was VP of Supply Chain Operations and Finance at Westaim Biomedical. He has a degree in history from the...
STEVENSVILLE, Md., Oct. 27, 2011 /PRNewswire-USNewswire/ -- Vapotherm announced today receiving FDA clearance for Precision Flow® Heliox, a high flow humidification system designed specifically for use with blended helium oxygen gas mixtures (Heliox). The product is part of Vapotherm's High Flow Specialty Gas Program for optimal conditioning of breathing gases. Heliox is used in a variety of respiratory applications such as upper airway obstruction, asthma, croup and COPD. "We are...
STEVENSVILLE, Md., Aug. 24, 2011 /PRNewswire-USNewswire/ -- Vapotherm, announced today receiving CE marking for Precision Flow® Heliox, a high flow humidification system designed specifically for use with blended helium oxygen gas mixtures (Heliox). The product is part of Vapotherm's High Flow Specialty Gas Program for optimal conditioning of breathing gases. Due to helium's lower density as compared to nitrogen, the primary gas in room air, breathing with heliox results in less airway...
STEVENSVILLE, Md., Aug. 16, 2011 /PRNewswire-USNewswire/ -- Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that its Precision Flow® system has been validated by Ikaria, Inc. and cleared by the FDA for the administration of nitric oxide via high flow nasal cannula. The product is part of Vapotherm's High Flow Specialty Gas Program for optimal conditioning of breathing gases. Hypoxic respiratory failure affects approximately...
STEVENSVILLE, Md., July 26, 2011 /PRNewswire-USNewswire/ -- Vapotherm announced today the launch of Flowrest®, a High Flow Therapy device developed specifically for homecare and other low acuity environments. The initial launch will focus on the U.S. and European markets. Vapotherm's Flowrest® is designed specifically for chronic respiratory patients in home and other extended care environments. According to the World Health Organization, chronic respiratory diseases impact hundreds...
STEVENSVILLE, Md., July 13, 2011 /PRNewswire-USNewswire/ -- Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that it has received approval from the Medical Device Bureau of Health Canada for the Precision Flow® Heliox device which will be launched later this year in the Canadian hospital market. The device is part of Vapotherm's High Flow Specialty Gas Program. "We are pleased to receive our license in Canada for Precision...
STEVENSVILLE, Md., July 12, 2011 /PRNewswire-USNewswire/ -- Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that it has signed a new exclusive distribution agreement with Hippo Medical of Seoul, Korea. Hippo will cover all of Korea for the Vapotherm acute care product line. "We are pleased to announce this new partnership with Hippo to bring high flow therapy to the Korean market," said Steve Orwig, Acute Care Manager with...
STEVENSVILLE, Md., Feb. 22, 2011 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Therapy (HFT(TM)) products, has received 510(k) clearance from the Food and Drug Administration (FDA) for the Flowrest® homecare device. The device also recently received CE marking. The Flowrest® delivers warmed, humidified high-flow breathing gases to patients via nasal cannula. Utilizing patent pending humidification and breathing circuit technology, the device is designed to...
STEVENSVILLE, Md., Jan. 6, 2011 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Therapy products, announced receiving CE marking for Flowrest®, a device designed for homecare and other low acuity environments. The Flowrest® device delivers warmed humidified high-flow breathing gases for treating spontaneously breathing patients via nasal cannula. Flowrest® is designed for ease of use in the home and includes an integrated blower and patent-pending...
